Login / Signup
Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?
Torsten Christ
Marc D Lemoine
Thomas Eschenhagen
Published in:
Nature communications (2021)
Keyphrases
</>
atrial fibrillation
catheter ablation
left atrial
endothelial cells
oral anticoagulants
left atrial appendage
direct oral anticoagulants
induced pluripotent stem cells
heart failure
heart rate
high glucose
pluripotent stem cells
blood pressure
coronary artery disease
left ventricular